Julie Culver

Title(s)Clinical Assistant Professor of Medicine (Clinician Edcuator)
SchoolKeck School of Medicine of Usc
AddressUSC Norris Comprehensive Cancer Center
Health Sciences Campus
Los Angeles CA 90089
Phone+1 323 865 0806
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Julie Culver, MS, LCGC, CCRP is the Director of Genetic Counseling at the USC Norris Cancer Hospital and is a Clinical Instructor of Medicine in the USC Keck School of Medicine. She provides cancer genetic counseling for individuals and family at risk of having inherited cancer syndromes.
    Her research pertains to genetic testing for hereditary cancer, medical decision-making following genetic testing, implementation of genetic testing, and participant engagement in genomics research. She has taught breast cancer risk assessment to health professionals and students since 2004.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. EPR24-111: The Clinical Effect of a Community-Based Genetic Testing Program. J Natl Compr Canc Netw. 2024 Apr 05; 22(2.5). Brabender D, Siegel E, Culver J, Comeaux J, Date A, Woodworth A. PMID: 38580284.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Systematic evidence review and meta-analysis of outcomes associated with cancer genetic counseling. Genet Med. 2024 01; 26(1):100980. Culver JO, Bertsch NL, Kurz RN, Cheng LL, Pritzlaff M, Rao SK, Stasi SM, Stave CD, Sharaf RN. PMID: 37688462.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Clinical implications of conflicting variant interpretations in the cancer genetics clinic. Genet Med. 2023 07; 25(7):100837. Zukin E, Culver JO, Liu Y, Yang Y, Ricker CN, Hodan R, Sturgeon D, Kingham K, Chun NM, Rowe-Teeter C, Singh K, Zell JA, Ladabaum U, McDonnell KJ, Ford JM, Parmigiani G, Braun D, Kurian AW, Gruber SB, Idos GE. PMID: 37057674; PMCID: PMC10416421.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Clinical and laboratory genetic counselor attitudes on the reporting of variants of uncertain significance for multigene cancer panels. J Genet Couns. 2023 06; 32(3):706-716. Chang EY, Solomon I, Culver JO, Gorman N, Comeaux JG, Lerman C, Quinn EA, Ekstein T. PMID: 36747331.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. ASO Author Reflections: A Green Light for Genetic Testing in All Patients with Breast Cancer. Ann Surg Oncol. 2023 02; 30(2):1026-1027. Culver JO. PMID: 36241948.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients. Ann Surg Oncol. 2023 Feb; 30(2):1017-1025. Culver JO, Freiberg Y, Ricker C, Comeaux JG, Chang EY, Banerjee V, Sturgeon D, Solomon I, Kagey J, Dobre MG, Carey J, Carr A, Cho S, Lu J, Kang IM, Patel K, Terando A, Ye JC, Li M, Lerman C, Spicer D, Nelson M. PMID: 36161375; PMCID: PMC9512964.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    7. Risk-reducing mastectomy decisions among women with mutations in high- and moderate- penetrance breast cancer susceptibility genes. Mol Genet Genomic Med. 2022 10; 10(10):e2031. Comeaux JG, Culver JO, Lee JE, Dondanville D, McArthur HL, Quinn E, Gorman N, Ricker C, Li M, Lerman C. PMID: 36054727; PMCID: PMC9544212.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Transcriptome analysis provides critical answers to the "variants of uncertain significance" conundrum. Hum Mutat. 2022 11; 43(11):1590-1608. Postel MD, Culver JO, Ricker C, Craig DW. PMID: 35510381; PMCID: PMC9560997.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    9. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. 2021 04 15; 127(8):1275-1285. Culver JO, Ricker CN, Bonner J, Kidd J, Sturgeon D, Hodan R, Kingham K, Lowstuter K, Chun NM, Lebensohn AP, Rowe-Teeter C, Levonian P, Partynski K, Lara-Otero K, Hong C, Morales Pichardo J, Mills MA, Brown K, Lerman C, Ladabaum U, McDonnell KJ, Ford JM, Gruber SB, Kurian AW, Idos GE. PMID: 33320347; PMCID: PMC8058169.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    10. Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D. J Natl Cancer Inst. 2020 12 14; 112(12):1242-1250. Yang X, Song H, Leslie G, Engel C, Hahnen E, Auber B, Horváth J, Kast K, Niederacher D, Turnbull C, Houlston R, Hanson H, Loveday C, Dolinsky JS, LaDuca H, Ramus SJ, Menon U, Rosenthal AN, Jacobs I, Gayther SA, Dicks E, Nevanlinna H, Aittomäki K, Pelttari LM, Ehrencrona H, Borg Å, Kvist A, Rivera B, Hansen TVO, Djursby M, Lee A, Dennis J, Bowtell DD, Traficante N, Diez O, Balmaña J, Gruber SB, Chenevix-Trench G, Investigators K, Jensen A, Kjær SK, Høgdall E, Castéra L, Garber J, Janavicius R, Osorio A, Golmard L, Vega A, Couch FJ, Robson M, Gronwald J, Domchek SM, Culver JO, de la Hoya M, Easton DF, Foulkes WD, Tischkowitz M, Meindl A, Schmutzler RK, Pharoah PDP, Antoniou AC. PMID: 32107557; PMCID: PMC7735771.
      View in: PubMed   Mentions: 83     Fields:    Translation:Humans
    11. Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells. Gynecol Oncol. 2020 12; 159(3):869-876. Ciccone MA, Adams CL, Bowen C, Thakur T, Ricker C, Culver JO, Maoz A, Melas M, Idos GE, Jeyasekharan AD, Matsuo K, Roman LD, Gruber SB, McDonnell KJ. PMID: 33032822; PMCID: PMC9893519.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    12. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. J Clin Oncol. 2020 03 01; 38(7):674-685. Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, Adank MA, Adlard J, Aittomäki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg Å, Blomqvist C, Claes KBM, Concannon P, Cuggia A, Culver JO, Damiola F, de Pauw A, Diez O, Dolinsky JS, Domchek SM, Engel C, Evans DG, Fostira F, Garber J, Golmard L, Goode EL, Gruber SB, Hahnen E, Hake C, Heikkinen T, Hurley JE, Janavicius R, Kleibl Z, Kleiblova P, Konstantopoulou I, Kvist A, Laduca H, Lee ASG, Lesueur F, Maher ER, Mannermaa A, Manoukian S, McFarland R, McKinnon W, Meindl A, Metcalfe K, Mohd Taib NA, Moilanen J, Nathanson KL, Neuhausen S, Ng PS, Nguyen-Dumont T, Nielsen SM, Obermair F, Offit K, Olopade OI, Ottini L, Penkert J, Pylkäs K, Radice P, Ramus SJ, Rudaitis V, Side L, Silva-Smith R, Silvestri V, Skytte AB, Slavin T, Soukupova J, Tondini C, Trainer AH, Unzeitig G, Usha L, van Overeem Hansen T, Whitworth J, Wood M, Yip CH, Yoon SY, Yussuf A, Zogopoulos G, Goldgar D, Hopper JL, Chenevix-Trench G, Pharoah P, George SHL, Balmaña J, Houdayer C, James P, El-Haffaf Z, Ehrencrona H, Janatova M, Peterlongo P, Nevanlinna H, Schmutzler R, Teo SH, Robson M, Pal T, Couch F, Weitzel JN, Elliott A, Southey M, Winqvist R, Easton DF, Foulkes WD, Antoniou AC, Tischkowitz M. PMID: 31841383; PMCID: PMC7049229.
      View in: PubMed   Mentions: 162     Fields:    Translation:Humans
    13. Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. JCO Precis Oncol. 2019 Mar; 3. Idos GE, Kurian AW, Ricker C, Sturgeon D, Culver JO, Kingham KE, Koff R, Chun NM, Rowe-Teeter C, Lebensohn AP, Levonian P, Lowstuter K, Partynski K, Hong C, Mills MA, Petrovchich I, Ma CS, Hartman AR, Allen B, Wenstrup RJ, Lancaster JM, Brown K, Kidd J, Evans B, Mukherjee B, McDonnell KJ, Ladabaum U, Ford JM, Gruber SB. PMID: 34322651; PMCID: PMC8260917.
      View in: PubMed   Mentions: 20     Fields:    
    14. Prospective Study of Cancer Genetic Variants: Variation in Rate of Reclassification by Ancestry. J Natl Cancer Inst. 2018 10 01; 110(10):1059-1066. Slavin TP, Van Tongeren LR, Behrendt CE, Solomon I, Rybak C, Nehoray B, Kuzmich L, Niell-Swiller M, Blazer KR, Tao S, Yang K, Culver JO, Sand S, Castillo D, Herzog J, Gray SW, Weitzel JN. PMID: 29618041; PMCID: PMC6249694.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    15. Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices. NPJ Genom Med. 2018; 3:7. Toland AE, Forman A, Couch FJ, Culver JO, Eccles DM, Foulkes WD, Hogervorst FBL, Houdayer C, Levy-Lahad E, Monteiro AN, Neuhausen SL, Plon SE, Sharan SK, Spurdle AB, Szabo C, Brody LC, BIC Steering Committee. PMID: 29479477; PMCID: PMC5814433.
      View in: PubMed   Mentions: 22  
    16. Patient communication of cancer genetic test results in a diverse population. Transl Behav Med. 2018 01 29; 8(1):85-94. Ricker CN, Koff RB, Qu C, Culver J, Sturgeon D, Kingham KE, Lowstuter K, Chun NM, Rowe-Teeter C, Lebensohn A, Levonian P, Partynski K, Lara-Otero K, Hong C, Petrovchich IM, Mills MA, Hartman AR, Allen B, Ladabaum U, McDonnell K, Ford JM, Gruber SB, Kurian AW, Idos GE. PMID: 29385580; PMCID: PMC6065549.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    17. Unexpected CDH1 Mutations Identified on Multigene Panels Pose Clinical Management Challenges. JCO Precis Oncol. 2017 Nov; 1:1-12. Lowstuter K, Espenschied CR, Sturgeon D, Ricker C, Karam R, LaDuca H, Culver JO, Dolinsky JS, Chao E, Sturgeon J, Speare V, Ma Y, Kingham K, Melas M, Idos GE, McDonnell KJ, Gruber SB. PMID: 35172483.
      View in: PubMed   Mentions: 24     Fields:    
    18. Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohort. Cancer Genet. 2016 Apr; 209(4):130-7. Ricker C, Culver JO, Lowstuter K, Sturgeon D, Sturgeon JD, Chanock CR, Gauderman WJ, McDonnell KJ, Idos GE, Gruber SB. PMID: 26908360; PMCID: PMC4835267.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    19. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer. Cancer Genet. 2016 Mar; 209(3):75-81. McDonnell KJ, Gallanis GT, Heller KA, Melas M, Idos GE, Culver JO, Martin SE, Peng DH, Gruber SB. PMID: 26774355; PMCID: PMC6447287.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    20. Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings. Genet Test Mol Biomarkers. 2015 Dec; 19(12):657-65. Blazer KR, Nehoray B, Solomon I, Niell-Swiller M, Culver JO, Uman GC, Weitzel JN. PMID: 26539620; PMCID: PMC4677543.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    21. Variants of uncertain significance in BRCA testing: evaluation of surgical decisions, risk perception, and cancer distress. Clin Genet. 2013 Nov; 84(5):464-72. Culver JO, Brinkerhoff CD, Clague J, Yang K, Singh KE, Sand SR, Weitzel JN. PMID: 23323793; PMCID: PMC3751990.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    22. Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions. Mol Diagn Ther. 2013 Feb; 17(1):31-47. Sorrell AD, Espenschied CR, Culver JO, Weitzel JN. PMID: 23355100; PMCID: PMC3627545.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    23. Closing the loop: action research in a multimodal hereditary cancer patient conference is an effective tool to assess and address patient needs. J Cancer Educ. 2012 Jun; 27(3):467-77. Espenschied CR, MacDonald DJ, Culver JO, Sand S, Hurley K, Banks KC, Weitzel JN, Blazer KR. PMID: 22610836; PMCID: PMC3540105.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns. 2012 Apr; 21(2):151-61. Riley BD, Culver JO, Skrzynia C, Senter LA, Peters JA, Costalas JW, Callif-Daley F, Grumet SC, Hunt KS, Nagy RS, McKinnon WC, Petrucelli NM, Bennett RL, Trepanier AM. PMID: 22134580.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    25. Personalized cancer genetics training for personalized medicine: improving community-based healthcare through a genetically literate workforce. Genet Med. 2011 Sep; 13(9):832-40. Blazer KR, Macdonald DJ, Culver JO, Huizenga CR, Morgan RJ, Uman GC, Weitzel JN. PMID: 21629123; PMCID: PMC3337331.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    26. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine. CA Cancer J Clin. 2011 Sep-Oct; 61(5):327-59. Weitzel JN, Blazer KR, MacDonald DJ, Culver JO, Offit K. PMID: 21858794; PMCID: PMC3346864.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    27. Health literacy, numeracy, and interpretation of graphical breast cancer risk estimates. Patient Educ Couns. 2011 Apr; 83(1):92-8. Brown SM, Culver JO, Osann KE, MacDonald DJ, Sand S, Thornton AA, Grant M, Bowen DJ, Metcalfe KA, Burke HB, Robson ME, Friedman S, Weitzel JN. PMID: 20554149; PMCID: PMC4041683.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    28. Development and evaluation of a decision aid for BRCA carriers with breast cancer. J Genet Couns. 2011 Jun; 20(3):294-307. Culver JO, MacDonald DJ, Thornton AA, Sand SR, Grant M, Bowen DJ, Burke H, Garcia N, Metcalfe KA, Weitzel JN. PMID: 21369831; PMCID: PMC3531556.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    29. Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat. 2011 Apr; 32(4):407-14. Kuiper RP, Vissers LE, Venkatachalam R, Bodmer D, Hoenselaar E, Goossens M, Haufe A, Kamping E, Niessen RC, Hogervorst FB, Gille JJ, Redeker B, Tops CM, van Gijn ME, van den Ouweland AM, Rahner N, Steinke V, Kahl P, Holinski-Feder E, Morak M, Kloor M, Stemmler S, Betz B, Hutter P, Bunyan DJ, Syngal S, Culver JO, Graham T, Chan TL, Nagtegaal ID, van Krieken JH, Schackert HK, Hoogerbrugge N, van Kessel AG, Ligtenberg MJ. PMID: 21309036.
      View in: PubMed   Mentions: 64     Fields:    Translation:Cells
    30. Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol. 2011 Jan; 12(1):49-55. Kempers MJ, Kuiper RP, Ockeloen CW, Chappuis PO, Hutter P, Rahner N, Schackert HK, Steinke V, Holinski-Feder E, Morak M, Kloor M, Büttner R, Verwiel ET, van Krieken JH, Nagtegaal ID, Goossens M, van der Post RS, Niessen RC, Sijmons RH, Kluijt I, Hogervorst FB, Leter EM, Gille JJ, Aalfs CM, Redeker EJ, Hes FJ, Tops CM, van Nesselrooij BP, van Gijn ME, Gómez García EB, Eccles DM, Bunyan DJ, Syngal S, Stoffel EM, Culver JO, Palomares MR, Graham T, Velsher L, Papp J, Oláh E, Chan TL, Leung SY, van Kessel AG, Kiemeney LA, Hoogerbrugge N, Ligtenberg MJ. PMID: 21145788; PMCID: PMC3670774.
      View in: PubMed   Mentions: 110     Fields:    Translation:HumansCells
    31. Breast cancer risk communication: assessment of primary care physicians by standardized patients. Genet Med. 2009 Oct; 11(10):735-41. Culver JO, Bowen DJ, Reynolds SE, Pinsky LE, Press N, Burke W. PMID: 19661809.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    32. Genetic assessment of breast cancer risk in primary care practice. Am J Med Genet A. 2009 Mar; 149A(3):349-56. Burke W, Culver J, Pinsky L, Hall S, Reynolds SE, Yasui Y, Press N. PMID: 19208375; PMCID: PMC2688688.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    33. Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA. 2007 Jun 20; 297(23):2587-95. Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR, Palomares MR, Lowstuter KJ, MacDonald DJ. PMID: 17579227.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    34. Results of a randomized study of telephone versus in-person breast cancer risk counseling. Patient Educ Couns. 2006 Dec; 64(1-3):96-103. Helmes AW, Culver JO, Bowen DJ. PMID: 16427245.
      View in: PubMed   Mentions: 41     Fields:    Translation:HumansPHPublic Health
    35. Effects of counseling Ashkenazi Jewish women about breast cancer risk. Cultur Divers Ethnic Minor Psychol. 2006 Jan; 12(1):45-56. Bowen DJ, Burke W, Culver JO, Press N, Crystal S. PMID: 16594854.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    36. Assessing breast cancer risk and BRCA1/2 carrier probability. Breast Dis. 2006-2007; 27:5-20. Culver J, Lowstuter K, Bowling L. PMID: 17917138.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    37. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns. 2004 Apr; 13(2):83-114. Trepanier A, Ahrens M, McKinnon W, Peters J, Stopfer J, Grumet SC, Manley S, Culver JO, Acton R, Larsen-Haidle J, Correia LA, Bennett R, Pettersen B, Ferlita TD, Costalas JW, Hunt K, Donlon S, Skrzynia C, Farrell C, Callif-Daley F, Vockley CW, National Society of Genetic Counselors. PMID: 15604628.
      View in: PubMed   Mentions: 98     Fields:    Translation:Humans
    38. Oncologists' opinions on genetic testing for breast and ovarian cancer. Genet Med. 2001 Mar-Apr; 3(2):120-5. Culver JO, Hull JL, Dunne DF, Burke W. PMID: 11280949.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    39. Genetic counseling for women with an intermediate family history of breast cancer. Am J Med Genet. 2000 Feb 28; 90(5):361-8. Burke W, Culver JO, Bowen D, Lowry D, Durfy S, McTiernan A, Andersen MR. PMID: 10706356.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    Julie's Networks
    Concepts (164)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (18)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.

    This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.